Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function

INTRODUCTION: Hepatorenal syndrome (HRS), a special form of acute kidney failure, is a rare, acute, life-threatening complication of cirrhosis and has a very poor prognosis. Terlipressin (TERLIVAZ(®)) is the first and only pharmacological treatment approved by Food and Drug Administration (September...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Xingyue, Bindra, Jas, Chopra, Ishveen, Niewoehner, John, Wan, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611877/
https://www.ncbi.nlm.nih.gov/pubmed/37812332
http://dx.doi.org/10.1007/s12325-023-02674-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611877/
https://www.ncbi.nlm.nih.gov/pubmed/37812332
http://dx.doi.org/10.1007/s12325-023-02674-z

Ejemplares similares